September 30,

December 31,

2024

2023

(in thousands)

Accrued clinical trial and preclinical costs

$

11,606

$

4,705

Compensation and benefits

8,844

10,011

Professional services

1,916

787

Other

392

750

Accrued research and development services (nil and $3.1
     million due to related party in 2024 and 2023, respectively)

—

5,004

Total accrued liabilities

$

22,758

$

21,257